Safety evaluation of immunomodulatory biopharmaceuticals: can we improve the predictive value of preclinical studies? [electronic resource]
- Human & experimental toxicology Apr 2000
- 205-7 p. digital
Publication Type: Journal Article
0960-3271
10.1191/096032700678815855 doi
Adjuvants, Immunologic--adverse effects Biopharmaceutics Drug Evaluation, Preclinical